Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
U-01 by Shanghai Unicar-Therapy Bio-Medicine Technology for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
U-01 is under clinical development by Shanghai Unicar-Therapy Bio-Medicine Technology and currently in Phase II for Relapsed Acute Myeloid Leukemia....
U-01 by Shanghai Unicar-Therapy Bio-Medicine Technology for Refractory Acute Myeloid Leukemia: Likelihood of Approval
U-01 is under clinical development by Shanghai Unicar-Therapy Bio-Medicine Technology and currently in Phase II for Refractory Acute Myeloid Leukemia....
U-01 by Shanghai Unicar-Therapy Bio-Medicine Technology for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia): Likelihood of Approval
U-01 is under clinical development by Shanghai Unicar-Therapy Bio-Medicine Technology and currently in Phase I for B-Cell Acute Lymphocytic Leukemia...